[Pharmwaste] BPA Ruling Flawed, Panel Says - FDA Ignored Scientific Evidence of Harm, Report Finds

DeBiasi,Deborah dldebiasi at deq.virginia.gov
Wed Oct 29 10:58:46 EDT 2008


http://www.washingtonpost.com/wp-dyn/content/article/2008/10/28/AR200810
2803406.html?wpisrc=newsletter&wpisrc=newsletter

BPA Ruling Flawed, Panel SaysFDA Ignored Scientific Evidence of Harm,
Report Finds


By Annys Shin
Washington Post Staff Writer
Wednesday, October 29, 2008; A13



The Food and Drug Administration ignored scientific evidence and used
flawed methods when it determined that a chemical widely used in baby
bottles and in the lining of cans is not harmful, a scientific advisory
panel has found.

In a highly critical report to be released today, the panel of
scientists from government and academia said the FDA did not take into
consideration scores of studies that have linked bisphenol A (BPA) to
prostate cancer, diabetes and other health problems in animals when it
completed a draft risk assessment of the chemical last month. The panel
said the FDA didn't use enough infant formula samples and didn't
adequately account for variations among the samples.

Taking those studies into consideration, the panel concluded, the FDA's
margin of safety is "inadequate". The panel is part of the Science
Board, a committee of advisers to the FDA commissioner, and was set up
to review the FDA's risk assessment of BPA.

Many of the studies that the panel said the FDA ignored were reviewed by
the National Toxicology Program, which concluded in September that it
had "some concern" that BPA can affect brain and behavioral development
in infants and small children.

Officials at FDA, which regulates the chemical's use in plastic food
containers, bottles, tableware and the plastic linings of food cans,
accepted some of the criticism in the report.

"FDA agrees that due to the uncertainties raised in some studies
relating to the potential effects of low doses of bisphenol-A that
additional research would be valuable," said spokeswoman Judy Leon. The
agency has commissioned new research on BPA.

The report adds fuel to the debate over whether to ban the use of BPA,
which is used to harden plastic, particularly in baby bottles and cans
of liquid formula. Infants are considered more vulnerable to the health
effects of many chemicals.

"The current levels of exposure are not safe," said Sarah Janssen, a
reproductive biologist with the Natural Resources Defense Council, an
environmental advocacy group. "We should get rid of it in food
containers."

The American Chemistry Council, a trade group that represents BPA
manufacturers, said its members would comply with whatever the FDA
decides to do.

"If the agency determines that existing margins of safety are
insufficient in infant applications, our member companies that
manufacture BPA will put processes in place to promptly phase out the
use of materials containing BPA in baby bottles and infant formula
packaging," ACC spokeswoman Tiffany Harrington said.

Retailers have already begun selling BPA-free baby bottles in response
to consumer concerns. This month, Canada banned its use in baby bottles.

House Committee on Energy and Commerce Chairman John D. Dingell
(D-Mich.) and Rep. Bart Stupak (D-Mich.), as well as several state
attorneys general, have called on formula-makers to remove BPA from
their products.

The report likely will be fodder for critics of FDA who have accused the
agency of relying too heavily on industry-funded studies. But it is
likely to put to rest charges by environmental groups and public health
advocates that the panel's chairman, Martin Philbert, co-director of the
University of Michigan's Risk Science Center, was influenced by grants
that his center received from Dow Chemical, a major BPA manufacturer.
Dow gave the center $15 million for research on dioxin.

The center also received $5 million from Charles Gelman, a retired
businessman who has been vocal in his support for BPA. Philbert has said
that those donations did not influence his work or the center's.

Deborah L. DeBiasi
Email:   dldebiasi at deq.virginia.gov
WEB site address:  www.deq.virginia.gov
Virginia Department of Environmental Quality
Office of Water Permit Programs
Industrial Pretreatment/Toxics Management Program
PPCPs, EDCs, and Microconstituents
Mail:          P.O. Box 1105, Richmond, VA  23218 (NEW!)
Location:  629 E. Main Street, Richmond, VA  23219
PH:         804-698-4028
FAX:      804-698-4032



More information about the Pharmwaste mailing list